Kraig Biocraft Laboratories, Inc. KBLB
$0.08
$0.00-1.35%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.69% | 47.83% | -107.91% | -21.02% | 29.55% |
| Total Depreciation and Amortization | -75.00% | 15.35% | -41.73% | 547.37% | -92.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9,672.73% | -99.75% | 19,322.22% | 107.64% | -4,026.67% |
| Change in Net Operating Assets | -38.37% | 104.47% | -37.03% | 10.52% | -17.57% |
| Cash from Operations | -17.84% | 2.68% | -4.24% | -1.98% | 15.22% |
| Capital Expenditure | -781.25% | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -67.06% | 51.36% | -- | -- |
| Cash from Investing | -119.64% | -67.77% | 55.26% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -50.00% | -- | -- | -- |
| Issuance of Common Stock | 142.85% | -36.67% | 55.40% | 309.10% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | 173.10% | -40.92% | 48.13% | 334.96% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 390.33% | -71.23% | 100.82% | 240.61% | 46.54% |